At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 17, 2026 at 17:11 ET
United Therapeutics CEO Martine Rothblatt and EVP Paul Mahon exercised stock options and sold shares in the open market, generating over $3.7 million in proceeds. The activity is part of a routine stock option exercise and partial sale of shares, not an outright open-market sell-off of owned shares. Director Judy Olian also sold a small portion of her holdings.
- CEO Martine Rothblatt exercised options for 38,000 shares (across multiple tranches) at $146.03 and $0 strike prices, with total intrinsic value of $4.17 million.
- Rothblatt sold 679 shares in open-market transactions totaling $356,253 in proceeds.
- EVP Paul Mahon exercised options for 16,600 shares at $146.03, with intrinsic value of $2.42 million, and sold 753 shares for $397,184.
- Director Judy Olian sold 200 shares for $106,000 in an open-market transaction.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access